The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.

about

The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.

Item

http://www.wikidata.org/entity/Q39290479

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@en

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@nl

type

Item

label

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@en

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@nl

prefLabel

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@en

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@nl

P1476

The expression pattern of Von ...... cell carcinoma in Upper Egypt.

@en

P2093

Abd-Alhady Mohammad Omar

http://www.w3.org/2001/XMLSchema#string

Eman Ahmed Mohammed

http://www.w3.org/2001/XMLSchema#string

Fayed Mohamad Nagi

http://www.w3.org/2001/XMLSchema#string

Mahmoud Rezk Abd-Elwahed Hussein

http://www.w3.org/2001/XMLSchema#string

Mohamed Galal Mostafa

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel VHL target genes and relationship to hypoxic response pathways

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents

c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22

The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene

pVHL function is essential for endothelial extracellular matrix deposition.

Localization of the 5’ end of the MCF2 oncogene to human chromosome 15ql5→q23

A functional genetic screen identifies TFE3 as a gene that confers resistance to the anti-proliferative effects of the retinoblastoma protein and transforming growth factor-beta.

P304

79-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/01913123.2010.544844

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21299348

http://www.w3.org/2001/XMLSchema#string